Michael Barbella, Managing Editor12.06.22
Electromed Inc. has appointed Brad Nagel as chief financial officer (CFO).
“We are thrilled to welcome Brad to the Electromed team,” Electromed President/CEO Kathleen Skarvan stated. “Brad is a dynamic financial executive with a superior track record of engineering growth and creating value in the medical device and retail industries. Through collaborative and cross-functional leadership, Brad has proven to be a high-impact leader with extensive background in developing high-performing teams. His financial, analytical and strategic acumen coupled with his leadership style makes Brad a strong cultural fit at this time when Electromed is poised for accelerating growth. I am confident he will be an excellent addition to the leadership team. I would also like to thank Michelle Wirtz for stepping into the interim chief financial officer role during our search for a permanent chief financial officer. Michelle has done a tremendous job in the interim position, exemplifying the spirit and dedication of the company, and will retain her existing role of corporate controller.”
Nagel brings to Electromed more than 15 years of financial leadership and strategic planning experience with Fortune 500 companies. Most recently, he was the Divisional CFO of Global Lung Health and Visualization at Medtronic and was a key contributor in driving the unit’s revenue growth. In that role, Nagel served as the primary business partner to the general manager and leadership team with a strategic focus on revenue growth, expense management, strategic product development and business development. Prior to his role as Divisional CFO, Nagel held various roles of increasing responsibility in finance, sales operations and accounting at Medtronic, Target Corporation, and TCF Bank.
“I am delighted to join Electromed at a time of significant opportunity for the company and its stakeholders. I look forward to working closely with the team to support Electromed’s growth strategies and long-term success,” Nagel said.
Electromed Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The company is headquartered in New Prague, Minn., and was founded in 1992.
“We are thrilled to welcome Brad to the Electromed team,” Electromed President/CEO Kathleen Skarvan stated. “Brad is a dynamic financial executive with a superior track record of engineering growth and creating value in the medical device and retail industries. Through collaborative and cross-functional leadership, Brad has proven to be a high-impact leader with extensive background in developing high-performing teams. His financial, analytical and strategic acumen coupled with his leadership style makes Brad a strong cultural fit at this time when Electromed is poised for accelerating growth. I am confident he will be an excellent addition to the leadership team. I would also like to thank Michelle Wirtz for stepping into the interim chief financial officer role during our search for a permanent chief financial officer. Michelle has done a tremendous job in the interim position, exemplifying the spirit and dedication of the company, and will retain her existing role of corporate controller.”
Nagel brings to Electromed more than 15 years of financial leadership and strategic planning experience with Fortune 500 companies. Most recently, he was the Divisional CFO of Global Lung Health and Visualization at Medtronic and was a key contributor in driving the unit’s revenue growth. In that role, Nagel served as the primary business partner to the general manager and leadership team with a strategic focus on revenue growth, expense management, strategic product development and business development. Prior to his role as Divisional CFO, Nagel held various roles of increasing responsibility in finance, sales operations and accounting at Medtronic, Target Corporation, and TCF Bank.
“I am delighted to join Electromed at a time of significant opportunity for the company and its stakeholders. I look forward to working closely with the team to support Electromed’s growth strategies and long-term success,” Nagel said.
Electromed Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The company is headquartered in New Prague, Minn., and was founded in 1992.
